July 18, 2011 (Press Release)
Orasi Medical Announces Clinical Results Measuring Alzheimer's Disease Severity Read more>>
May 17, 2011 (Press Release)
Rajiv Khosla named President and CEO; Robert F. Butz joins the Board of Directors Read more>>
April 12, 2011 (Press Release)
Orasi Medical Partners with Biogen Idec to Use Its Novel Biomarker Technology MEG functional imaging biomarkers to be utilized in clinical neuroscience development Read more>>
October 28, 2010
Post-traumatic stress disorder: a right temporal lobe syndrome? Recently published study using MEG suggests that a small area of the brain, just above the right ear, could be the key to understanding how post traumatic stress disorder works.Researchers from the Minneapolis VA Medical Center say brain scans of PTSD patients show unusual activity in the part of the brain responsible for memory. Read more>>
September 22, 2010
Orasi Medical Partners to Improve Neurological Drug Development Featured in FierceBiotech, Orasi Medical, announced that it has entered an agreement with Novartis Pharmaceuticals Corporation (Novartis) to develop a novel central nervous system (CNS) biomarker. Read more>>
September 17, 2010
Orasi Medical lands Novartis
Orasi Medical Inc., a company that’s developed technology used to identify brain signals, has landed another major partner: Novartis. Read more>>.
September 9, 2010 (Press Release)
Orasi Medical partners with Novartis Pharmaceuticals Novartis Pharmaceuticals and Orasi Medical enter agreement to develop CNS biomarkers. Read more>>.
August 3, 2010 (Press Release)
Orasi Medical and Elekta Jointly Release White Paper on Functional Brain Mapping using Elekta Neuromag Technology
MEG can accelerate drug development, reduce costs and improve CNS drug innovation Read more>>.
June 18, 2010
Orasi wins client to gauge drug potential
Orasi Medical Inc., a startup that’s marketing technology used to identify tiny magnetic signals in the brain, has landed its first paying customer: pharmaceutical giant Lundbeck. Read more>>.
June 15, 2010 (Press Release)
Orasi Medical partners with Lundbeck
Lundbeck enters Agreement with Orasi Medical to evaluate the effect of CNS drugs on the human brain. Read more>>.
May 28, 2010
Reading Baby Brains
Understanding how interconnected circuits develop, and how babies think, could lead to a host of new insights into everything from autism to language acquisition. Using magnetoencephalography, for the first time, researchers are able to see detailed activity in an active baby's brain. Read more>>.
March 24, 2010
Orasi Medical close to inking major licensing deal(s) with Big Pharma
Orasi Medical Inc., the University of Minnesota spin-off developing software to speed drug trials, is close to signing a deal to license its technology to one or more major pharmaceutical companies. Read more>>.
January 19, 2010 (Press Release)
Orasi Medical wins Red Herring 100 Global Award
Red Herring's editorial staff selected Orasi Medical from more than a thousand global companies as one of the Top 100 Global which recognizes the most promising technology ventures in the world. Read more>>.
January 18, 2010
Post-traumatic stress disorder (PTSD) diagnosed with MEG
With more than 90% accuracy, researchers were able to differentiate PTSD patients from healthy control subjects using synchronous neural interactions (SNI) test, the test that is one of the core patents of Orasi Medical's technology engine. Read more>>
May 15, 2009 (Press Release)
Orasi Medical wins Red Herring 100 North America Award
Orasi Medical nabs its first ever Red Herring Award. Selected from more than a thousand US based companies, Orasi Medical is recognized for its technological innovation, management strength, and financial health. Read more>>.
May 15, 2009
Diagnosing a Minnesota niche in medical marketplace
Orasi Medical is featured as a Minnesota-based diagnostic company that can help speed drugs to market. Story focuses on how Minnesota has a growing base of businesses that provide breakthrough diagnostic technologies for the pharmaceutical industry. Read more>>
May 12, 2009 (Press Release)
Orasi Medical completes series B financing - $3.5M
Announcement of a Series B finance closing for Orasi Medical to expand the development and use of its diagnostic test for use in the pharmaceutical and clinical markets. Read more>>.
August 30, 2007
Magnetic Personalities
An early report about University of Minnesota professor, Dr. Apostolos Georgopoulos, the inventor of the technology licensed by Orasi Medical. This Economist article details the early work of Dr. Georgopoulos as he learned how to adapt MEG (magneto-encephalography) technology to measure electrical activity of brain cells and then applied that knowledge to develop a statistical model to diagnose common brain-centered disorders including schizophrenia and Alzheimer's. Read more>>.
August 24, 2007
Magnetic test for brain disorders
Provides financial readers an executive overview of the MEG technology and its insightful diagnostic application by Dr. Georgopoulos at the University of Minnesota. Read more>>.
August 24, 2007
Brain test could help make earlier diagnoses
A technique developed by University of Minnesota scientist shows a promise in detecting several neurological disorders for which there is no other single test. The SNI test is surprisingly accurate in the assessment of 300 patients and healthy volunteers. Read more>>.
August 22, 2007
MEG differentiates functional brain disease
This research report comments on how "assessing the functional status of the brain is far from straightforward. Unlike other organs of the body, there are currently no good tests of brain function available. Instead, physicians have to rely on behavioral examination. That could be about to change, however; with the demonstration that magnetoencephalography (MEG), the non-invasive measurement of magnetic fields associated with neuronal activity, can be used to diagnose functional brain disorders." Read more>>.